Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients

被引:36
|
作者
Martin-Pena, Almudena [1 ]
Aguilar-Guisado, Manuela [1 ,2 ]
Espigado, Ildefonso [1 ,3 ]
Parody, Ricardo [3 ]
Cisneros, Jose Miguel [1 ,2 ]
机构
[1] Spanish Network Res Infect Dis REIPI, Seville, Spain
[2] Univ Hosp Virgen Rocio, Dept Infect Dis, Seville, Spain
[3] Univ Hosp Virgen Rocio, Dept Hematol, Seville, Spain
关键词
allogeneic stem cell; infection; mortality; risk factors; transplantation; CYTOMEGALOVIRUS-INFECTION; CLINICAL-FEATURES; FUNGAL-INFECTIONS; PERIPHERAL-BLOOD; RISK-FACTORS; MARROW; PREVENTION; OUTCOMES; DISEASE; ADULT;
D O I
10.1111/j.1399-0012.2010.01286.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
This is a prospective, observational study of a consecutive cohort of allogeneic hematopoietic stem cell transplantation (allo-HSCT) adult recipients conducted between July 2003 and May 2006, with the aim of identifying the current incidence, etiology, risk factors for infections and associated mortality up to two yr after allo-HSCT. Seventy-four episodes of infection were recorded in 38 patients, 50 consecutive adult patients underwent 54 allo-HSCT. The incidence of infection was 1.36 (68/50) episodes/patient after the first year of transplantation and 1.48 (74/50) episodes/patient after first two yr of transplantation. The most common syndrome was cytomegalovirus (CMV) infection, followed by catheter-related bloodstream infection and pneumonia. An etiological diagnosis was established in 85.1% of the episodes. Bacteria were the most common etiology (55.5%), followed by viruses (41.3%) and fungi (4.8%). CMV was the most common viral agent (73%), and all fungal infections were caused by molds. Myeloablative conditioning regimen, chronic graft-versus-host disease, and medical complications post-transplant were independent risk factors for infection. The global mortality two yr after transplantation was 32%, and death was infection related in 12%. In spite of advances, infections continue to be a common cause of morbidity and mortality following allo-HSCT.
引用
收藏
页码:468 / 474
页数:7
相关论文
共 50 条
  • [21] Immune Deficits in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Mir, Muhammad A.
    Battiwalla, Minoo
    [J]. MYCOPATHOLOGIA, 2009, 168 (06) : 271 - 282
  • [22] The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
    Miriam Ciáurriz
    Amaya Zabalza
    Lorea Beloki
    Cristina Mansilla
    Estela Pérez-Valderrama
    Mercedes Lachén
    Eva Bandrés
    Eduardo Olavarría
    Natalia Ramírez
    [J]. Cellular and Molecular Life Sciences, 2015, 72 : 4049 - 4062
  • [23] Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Silva, Fernando
    Martins, Antonio
    Ferraz, Paula
    Lopes, Diogo
    Bastos, Juliana
    Araujo, Joana
    Trigo, Fernanda
    Pinto, Ricardo
    Silva-pinto, Andre
    [J]. ACTA MEDICA PORTUGUESA, 2024,
  • [24] PROCALCITONIN IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (AHSCT) RECIPIENTS
    Watson, T. M.
    Fry, T. J.
    Jacobsohn, D. A.
    Sande, J.
    Yates, B.
    Stevenson, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S268 - S268
  • [25] The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
    Ciaurriz, Miriam
    Zabalza, Amaya
    Beloki, Lorea
    Mansilla, Cristina
    Perez-Valderrama, Estela
    Lachen, Mercedes
    Bandres, Eva
    Olavarria, Eduardo
    Ramirez, Natalia
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (21) : 4049 - 4062
  • [26] Immune Deficits in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Muhammad A. Mir
    Minoo Battiwalla
    [J]. Mycopathologia, 2009, 168 : 271 - 282
  • [27] Red Cell Alloimmunization Rates in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Prokopchuk-Gauk, Oksana
    Prokopishyn, Nicole L.
    McCarthy, Joanna
    Shabani-Rad, Meer-Taher
    [J]. BLOOD, 2016, 128 (22)
  • [28] Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients
    E Lengliné
    S Chevret
    A-S Moreau
    F Pène
    F Blot
    J-H Bourhis
    A Buzyn
    B Schlemmer
    G Socié
    E Azoulay
    [J]. Bone Marrow Transplantation, 2015, 50 : 840 - 845
  • [29] Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
    R Greco
    M C Barbanti
    MT Lupo Stranghellini
    F Giglio
    M Morelli
    C Messina
    A Forcina
    C Oltolini
    S Piemontese
    P Scarpellini
    S Marktel
    A Assanelli
    M Carrabba
    L Vago
    C Corti
    M Bernardi
    J Peccatori
    F Ciceri
    [J]. Bone Marrow Transplantation, 2016, 51 : 1022 - 1024
  • [30] Study of cytomegalovirus resistance in allogeneic hematopoietic cell transplant recipients
    Guiu, Alba
    Lopez-Aladid, Ruben
    Cardenoso, Laura
    Mar Mosquera, Maria
    de la Camara, Rafael
    Angeles Marcos, Maria
    [J]. MEDICINA CLINICA, 2020, 154 (11): : 433 - 439